Serial #79137107
LIVE

Serial Number

79137107

Owner

Valneva Austria GmbH

Attorney

Christina M. Licursi

Filing Date

Jun 18, 2013

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79137107 Trademark

Serial Number: 79137107 • Registration: 4705701

Serial #79137107 is a trademark filed by Valneva Austria GmbH on June 18, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Valneva Austria GmbH (13 trademarks)

Campus Vienna Biocenter 3
Vienna A1030 , AT

Entity Type: 16

Trademark Details

Filing Date

June 18, 2013

Registration Date

March 24, 2015

Published for Opposition

January 6, 2015

Goods & Services

Chemical and biological preparations used in industry, science and agriculture, namely, biotechnological and biological substances in the nature of cells, cell lines, nucleic acids, recombinant proteins, antigens, blood sera, antibodies and fragments thereof other than for medical or veterinary use; biotechnological products, namely, diagnostic preparations for research and diagnostic uses; biological viral preparations and biological preparations for use in cell cultures other than for medical or veterinary use; bacterial and viral substances other than for medical and veterinary uses; chemicals and biological chemical preparations for use in medical science, namely, for use in biochemical and clinical research; microorganisms, viruses, viral vectors, [ nucleic acids, ] other than for medical or veterinary purposes

Scientific research and pharmaceutical development services; scientific research services in the medical, pharmaceutical and veterinary field; scientific and industrial research in particular in the field of biology, molecular biology, cell biology, biotechnology, bacteriology, immunology, [ genetics, ] medicine, pharmacology, virology, chemistry, scientific research of vaccines, [ antibiotics, ] immunological products for human and veterinary uses; research and development for novel products for the developing world; technical consultancy relating to scientific research in the scientific, medical and veterinary domain; scientific research and development and establishment of scientific and industrial research in particular for the preparation of cells, cell lines, proteins, viruses, human and animal materials; development of vaccines; [ development of medical diagnosis techniques, therapy and test methods; ] [ medical and scientific research in the field of diagnostic and prognostic analysis of human, animal, and cellular diseases; medical and scientific research in the field of diagnostic and prognostic analysis with the help of cell lines, human and animal material, microorganisms, molecules; ] chemical, medical, pharmaceutical and bacteriological scientific research

Pharmaceutical products for human and veterinary uses for treatment of infectious diseases, autoimmune disorders, cancer, immunological diseases; medical preparations, namely, diagnostic preparations for medical use; chemical preparations for pharmaceutical and medical purposes, namely, infectious diseases, autoimmune disorders, cancer, immunological diseases; biotechnological preparations for medical purposes, namely, medical diagnostic reagents; proteins, viral substances, immunological substances, bacterial substances, enzymatic substances, vaccines and biopharmaceutical preparations for use in human and veterinary medicine for treatment of infectious diseases, autoimmune disorders, cancer, immunological diseases; diagnostic preparations for use in human and veterinary medicine; chemical reagents for medical and veterinary purposes; cell cultures, microorganisms and viruses for medical and veterinary use; adjuvants used for medical and veterinary uses; antibiotic substances; vaccines; living cells and microorganisms as well as viral vectors, proteins, peptides and nucleic acids or complexes of these molecules for medical and veterinary purposes; antibodies and fragments thereof for use in disease testing; cells for medical, pharmaceutical and veterinary uses

Filing History

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jan 29, 2026 RHRD
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 9, 2026 INPR
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jan 8, 2026 RHRD
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 9, 2025 71AG
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 9, 2025 71AG
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 9, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 5, 2025 APRE
TEAS SECTION 71 RECEIVED
Dec 27, 2024 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 24, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
May 18, 2023 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Oct 15, 2022 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 21, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 21, 2021 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 20, 2021 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Apr 16, 2021 PR75
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 14, 2021 EROP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 30, 2021 LIMN
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Mar 29, 2021 PR75
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 29, 2021 EROP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 7, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 7, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 7, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 7, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 7, 2021 COAR
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Dec 18, 2020 RHRD
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jul 29, 2020 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 28, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Jul 8, 2020 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 24, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2019 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 6, 2018 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 10, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 21, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 6, 2015 FICS
FINAL DISPOSITION PROCESSED
Aug 6, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2015 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 3, 2015 OPNX
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2015 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 18, 2015 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jan 3, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 17, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 17, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 4, 2014 PREV
ASSIGNED TO LIE
Dec 3, 2014 ALIE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 27, 2014 ADCH
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 24, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2014 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2014 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2014 TROA
REFUSAL PROCESSED BY IB
Nov 16, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2013 RFCS
REFUSAL PROCESSED BY MPU
Oct 29, 2013 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 25, 2013 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 24, 2013 RFCR
NON-FINAL ACTION WRITTEN
Oct 23, 2013 CNRT
ASSIGNED TO EXAMINER
Oct 21, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 18, 2013 REPR